IL262677B2
Intracellular delivery of biomolecules to suppress an immune response or to induce tolerance to an antigen in an individual
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both waysCites: the store holds 2 of 3
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO2011051346A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-3,16-25,35-39 |
| WO2013059343A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-3,16-25,35-39 |
| RAVILLA, SRINU, BABU RAO CHANDU, AND SREEKANTH NAMA., ERYTHROCYTES AS CARRIER FOR DRUGS, ENZYMES AND PEPTIDES., 28 April 2012 (2012-04-28) | Non-patent | – | – | Search report | – |
| ZHANG, HUANG-GE, ET AL., INDUCTION OF SPECIFIC T-CELL TOLERANCE BY ADENOVIRUS-TRANSFECTED, FAS LIGAND-PRODUCING ANTIGEN-PRESENTING CELLS., 1 November 1998 (1998-11-01) | Non-patent | – | – | Search report | – |
23 members in 11 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 201662331368 | United States of America | P | |
| 62331368 | United States of America | – | |
| 2017030932 | United States of America | W |
Members23
| Document | Office | Kind | |
|---|---|---|---|
| CA3023092A1 | Canada | A1 | |
| WO2017192785A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2017259987A1 | Australia | A1 | |
| SG11201809437TA | Singapore | A | |
| IL262677A | Israel | A | |
| KR20190003735A | Republic of Korea | A | |
| CN109415741A | China | A | |
| EP3452604A1 | European Patent Office (EPO) | A1 | |
| US2019111082A1 | United States of America | A1 | |
| JP2019519483A | Japan | A | |
| RU2018142317A | Russian Federation | A | |
| RU2018142317A3 | Russian Federation | A3 | |
| JP2021176904A | Japan | A | |
| RU2770492C2 | Russian Federation | C2 | |
| KR102430856B1 | Republic of Korea | B1 | |
| AU2017259987B2 | Australia | B2 | |
| JP2024079824A | Japan | A | |
| JP7602702B2 | Japan | B2 | |
| US12201652B2 | United States of America | B2 | |
| IL262677B1 | Israel | B1 | |
| EP3452604B1 | European Patent Office (EPO) | B1 | |
| US2025108071A1 | United States of America | A1 | |
| IL262677B2This record | Israel | B2 |
Numbers
- Publication
- 262677
- Application
- 262677
Titles2
- English
- Intracellular delivery of biomolecules to suppress an immune response or to induce tolerance to an antigen in an individual
- Hebrew
- מתן תוך -תאי של ביומוליקולות לדיכוי תגובה חיסונית או לגרימת סבילות לאנטיגן בפרט
Classification
- CPC, 36
- C12N15/87
- A61K35/18
- A61K35/19
- A61K2039/507
- A61K39/001
- A61K2039/5154
- A61K2039/572
- A61K2039/6006
- A61P37/06
- A61K2039/62
- A61K2039/64
- A61K40/10
- A61K2121/00
- A61K40/32
- A61K2300/00
- A61K40/40
- A61K40/24
- A61K40/421
- A61K40/46
- A61K39/385
- A61K39/461
- A61K39/4622
- A61K39/4632
- A61K39/4634
- C12M3/06
- A61K39/464
- A61K39/464411
- A61K39/4645
- A61K39/464838
- C12M23/16
- C12N5/0644
- C12M1/12
- C12N15/85
- C12N5/0641
- A61K40/34
- A61K40/4285
- IPC, 10
- A61K35 18
- A61K35 19
- A61K39 00
- A61K39 385
- A61P37 06
- C12N15 85
- C12N15 87
- C12M3 06
- C12N5 078
- C12M1 12